-+ 0.00%
-+ 0.00%
-+ 0.00%
The US Food and Drug Administration requires that standalone applications must be labeled if they are critical to safe use or clinical benefit.
Share
Listen to the news
The US Food and Drug Administration requires that standalone applications must be labeled if they are critical to safe use or clinical benefit.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending